IRIX
NASDAQ
$0.92
IRIDEX Corp (IRIX)
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.
Sector:
Healthcare
Industry:
Medical Devices
Target: $2.75 (+200.51%)
Market Cap
$18M
PEG Ratio
0.94
Free Cash Flow Yield
-13.87%
Beta (5Y)
1.05
Price Chart
Valuation
Market Cap$18M
Forward P/E769.23
PEG0.94
P/S0.32
P/B331.20
Profitability
Total Revenue (TTM)$53M
Gross Profit (TTM)$19M
EBITDA-$2.20M
Profit Margin-4.4%
Operating Margin-2.7%
EPS-$0.19
Financial Health
Free Cash Flow Yield-13.87%
Growth & Risk
EPS 5Y CAGR-16.26%
Revenue 5Y CAGR+6.00%
Beta (5Y)1.05
Sharpe Ratio-0.17